Comparison

Anti-Mouse TIM-1 (CD365) - Purified in vivo PLATINUM™ Functional Grade

Item no. LEIN-T744-25mg
Manufacturer Leinco Technologies
Amount 25 mg
Quantity options 100 mg 1 mg 25 mg 50 mg 5 mg
Category
Type Antibody Monoclonal
Specific against other
ECLASS 10.1 42030590
ECLASS 11.0 42030590
UNSPSC 12352203
Shipping Condition Cool pack
Available
Manufacturer - Category
All|Primary Monoclonal Antibodies>Immune Checkpoints|Purified in vivo Functional Grade>Platinum Purified Bulk Antibodies
Manufacturer - Targets
TIM-1 (CD365)
Shipping Temperature
2 - 8°C Wet Ice
Storage Conditions
Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.
Product Description
TIM-1 is a member of the T cell immunoglobulin mucin gene family and encodes a cell-surface
glycoprotein consisting of an immunoglobulin variable-region-like domain (IgV), mucin-like
domain, transmembrane domain, and intracellular tail1, 2. TIM-1 promotes activated T cell
survival and plays a role in immunopathology2. TIM-1 is also expressed by tubules injured by
renal disease and in this context is known by its alternative name, kidney injury molecule-1
(KIM-1). Renal expression of TIM-1 is associated with dedifferentiation of epithelial cells and is
involved in the phagocytosis of apoptotic debris. TIM-1 also plays a role in immune responses
and is linked to airway hypersensitivity in mice and asthma, eczema, and rheumatoid arthritis in
humans1. TIM-1 was first identified as a hepatitis A virus cellular receptor1. TIM-4 is a natural
ligand of TIM-1.
RMT1-10 was generated by immunizing SD rats with full-length TIM-1-Ig containing both the
IgV and mucin domains1. Lymph nodes were fused with P3U1 myeloma cells. Resulting
hybridomas were screened for binding to mouse TIM-1-transfected CHO cells.
RMT1-10 binds to full-length and mucinless forms of TIM-1, suggesting its epitope resides in
the IgV domain1. Blocking TIM-1 in culture via the addition of RMT1-10 results in reduced T
cell proliferation, IFN-γ and IL-17 inhibition, and induction of the Th2 cytokines IL-4 and IL-101. Additionally, RMT1-10 significantly improves the survival rate of corneal allografts3, 4 and
attenuates atherosclerosis development and progression by expanding atheroprotective B1a cells5 in mice.
Concentration
≥ 5.0 mg/ml
Formulation
This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.
Antigen Distribution
TIM-1 is expressed on activated T cells, both Th1 and Th2 cells after CD4 +
T cell polarization, and kidney cells.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 25 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close